Scientific article
English

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

Published in

Drug development and industrial pharmacy, vol. 37, no. 9, p. 1100-1109

Publication date

2011

Abstract

In recent years, many achievements have been realized in the therapy of inflammatory bowel disease (IBD) although its etiology remains unknown. Thus IBD treatment is symptomatic and targets general inflammatory mechanisms. Oral formulations containing 5-aminosalicylic acid (5-ASA) have become the standard therapy for mild-to-moderate IBD.

Keywords

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
  • Clinical Trials as Topic
  • Drug Compounding/methods
  • Drug Delivery Systems/methods
  • Humans
  • Inflammatory Bowel Diseases/drug therapy/physiopathology
  • Mesalamine/administration & dosage

UNIGE affiliation entities

Not a UNIGE publication

Citation (ISO format)

BAUTZOVA, Tereza, RABIŠKOVÁ, Miloslava, LAMPRECHT, Alf. Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease. In: Drug development and industrial pharmacy, 2011, vol. 37, n° 9, p. 1100–1109. doi: 10.3109/03639045.2011.560156

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0363-9045
883views
0downloads

Technical informations

Creation

23/05/2017 15:26:00

First validation

23/05/2017 15:26:00

Update

15/03/2023 01:43:20

Status update

15/03/2023 01:43:20

Last indexation

31/10/2024 07:01:53
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated